🔎 Trials Near Me

Home › Overweight › Virginia › Arlington

Pag-aaral pangklinika para sa Overweight sa Arlington, VA

Isang pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Arlington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Nagre-recruitPhase 3
  • Research Site, Manassas · 22 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07776509

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Nagre-recruitPhase 3
  • Manassas Clinical Research Center, Manassas · 22 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07351058

Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes

Nagre-recruitPhase 3
  • Virginia Nephrology Group, Arlington
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07866066

A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes

Nagre-recruitPhase 3
  • Manassas Clinical Research Center, Manassas · 22 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07843485

A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

Nagre-recruitPhase 3
  • Washington Center for Weight Management and Research, Arlington
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07881458

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Nagre-recruitPhase 3
  • Research Site, Arlington
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07784725

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Nagre-recruitPhase 3
  • Research Site, Manassas · 22 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07784270

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 2
  • Washington Center For Weight Management And Research /ID# 282047, Arlington
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07752979

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
  • ACCOMPLISH-2 Research Site, Burke · 11 mi ang layo
  • ACCOMPLISH-2 Research Site, Manassas · 22 mi ang layo
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT07654374

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Nagre-recruitPhase 3
  • Washington Center for Weight Management and Research, Inc, Arlington
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Nagre-recruitPhase 3
  • Manassas Clinical Research Center Inc, Burke · 11 mi ang layo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07684144

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Nagre-recruitPhase 3
  • Washington Cntr Weight Mgmt, Arlington
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07720271

Pag-aaral para sa Overweight sa ibang lungsod

Iba pang pag-aaral sa Arlington

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.